{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:16:28Z","timestamp":1788380188183,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":31,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128899","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:56:20Z","timestamp":1786593380000},"page":"128899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Updating the evidence on brighton collaboration's GAIA maternal immunisation case definitions: a systematic review of performance and implementation challenges"],"prefix":"10.1016","volume":"89","author":[{"given":"Robert","family":"Mboizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Le Doare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare L.","family":"Cutland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor M.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah G.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"49","key":"10.1016\/j.vaccine.2026.128899_bb0005","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1016\/j.vaccine.2016.07.006","article-title":"Global alignment of immunization safety assessment in pregnancy - the GAIA project","volume":"34","author":"Bonhoeffer","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128899_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2024.100464","article-title":"Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review","author":"Davies","year":"2024","journal-title":"Vaccine X Elsevier Ltd"},{"key":"10.1016\/j.vaccine.2026.128899_bb0015","first-page":"1","article-title":"Standardizing case definitions for monitoring the safety of maternal vaccines globally: GAIA definitions, a review of progress to date","volume":"00","author":"Davies","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128899_bb0020","first-page":"108","article-title":"Use of routinely collected \u201creal-world\u201d data for the postlicensure safety assessment of vaccination during pregnancy","volume":"44","author":"Regan","year":"2025"},{"issue":"48 Pt A","key":"10.1016\/j.vaccine.2026.128899_bb0025","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1016\/j.vaccine.2017.03.103","article-title":"Immunization in pregnancy clinical research in low- and middle-income countries - study design, regulatory and safety considerations","volume":"35","author":"Kochhar","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128899_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2021.100123","article-title":"WHO global vaccine safety multi-country collaboration project on safety in pregnancy: assessing the level of diagnostic certainty using standardized case definitions for perinatal and neonatal outcomes and maternal immunization","volume":"9","author":"Stuurman","year":"2021","journal-title":"Vaccine X"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128899_bb0035","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/INF.0000000000003261","article-title":"Applicability of the GAIA maternal and neonatal outcome case definitions for the evaluation of adverse events following vaccination in pregnancy in high-income countries","volume":"40","author":"Watson","year":"2021","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.vaccine.2026.128899_bb0040","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2026.128899_bb0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128899_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2026.128952","article-title":"Baseline adverse birth outcomes in a prospective pregnancy cohort in Uganda: Evidence to inform maternal vaccine readiness","author":"Davies","year":"2026","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128899_bb0055","series-title":"Vaccine safety surveillance in Kenya using GAIA standards: a feasibility assessment of existing national and subnational research and program systems [internet]","author":"Izulla","year":"2023"},{"issue":"26","key":"10.1016\/j.vaccine.2026.128899_bb0060","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1016\/j.vaccine.2022.04.073","article-title":"Assessing the feasibility of passive surveillance for maternal immunization safety utilizing archival medical records in Kinshasa, Democratic Republic of the Congo","volume":"40","author":"Gadoth","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128899_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/jcv2.70085","article-title":"Maternal influenza vaccination during pregnancy and risk of autism spectrum disorder in the offspring","author":"Neeman","year":"2025","journal-title":"JCPP Advances"},{"key":"10.1016\/j.vaccine.2026.128899_bb0070","article-title":"Capability and feasibility of the global alignment of immunisation safety assessment in pregnancy criteria for the assessment of pregnancy and birth outcomes in Kinshasa, Democratic Republic of the Congo: a prospective cohort study","volume":"1","author":"Arena","year":"2023","journal-title":"BMJ Glob Health"},{"issue":"22","key":"10.1016\/j.vaccine.2026.128899_bb0075","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/j.vaccine.2019.03.074","article-title":"Immunization in pregnancy safety surveillance in low and middle-income countries- field performance and validation of novel case definitions","volume":"37","author":"Kochhar","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128899_bb0080","series-title":"Obstetric and neonatal outcomes in South Africa [internet]","author":"Cutland","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128899_bb0085","series-title":"Guidance for best practices for clinical trials","author":"World Health Organization","year":"2024"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128899_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjgh-2018-001065","article-title":"Use of routinely collected electronic healthcare data for postlicensure vaccine safety signal detection: a systematic review","volume":"4","author":"Mesfin","year":"2019","journal-title":"BMJ Glob Health"},{"issue":"49","key":"10.1016\/j.vaccine.2026.128899_bb0095","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1016\/j.vaccine.2016.03.047","article-title":"Congenital anomalies: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"DeSilva","year":"2016","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2026.128899_bb0100","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1016\/j.vaccine.2018.09.033","article-title":"Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: a feasibility assessment","volume":"36","author":"Stuurman","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128899_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12884-022-05291-w","article-title":"Comparison of adverse pregnancy and birth outcomes using archival medical records before and during the first wave of the COVID-19 pandemic in Kinshasa, Democratic Republic of Congo: a facility-based, retrospective cohort study","volume":"23","author":"Arena","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"issue":"49","key":"10.1016\/j.vaccine.2026.128899_bb0110","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1016\/j.vaccine.2016.03.044","article-title":"Stillbirth: case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data","volume":"34","author":"Tavares Da Silva","year":"2016","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2026.128899_bb0115","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1016\/j.vaccine.2016.03.040","article-title":"Neonatal death: case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"Pathirana","year":"2016","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2026.128899_bb0120","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.vaccine.2016.03.042","article-title":"Maternal death: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"Patwardhan","year":"2016","journal-title":"Vaccine"},{"issue":"48 Pt A","key":"10.1016\/j.vaccine.2026.128899_bb0125","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1016\/j.vaccine.2017.01.044","article-title":"Congenital microcephaly: case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation","volume":"35","author":"DeSilva","year":"2017","journal-title":"Vaccine"},{"issue":"48 Pt A","key":"10.1016\/j.vaccine.2026.128899_bb0130","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1016\/j.vaccine.2017.01.042","article-title":"Fetal growth restriction: case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"35","author":"Easter","year":"2017","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2026.128899_bb0135","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/j.vaccine.2016.03.043","article-title":"Non-reassuring fetal status: case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"Gravett","year":"2016","journal-title":"Vaccine"},{"issue":"48 Pt A","key":"10.1016\/j.vaccine.2026.128899_bb0140","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1016\/j.vaccine.2017.01.081","article-title":"Antenatal bleeding: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"35","author":"Prabhu","year":"2017","journal-title":"Vaccine"},{"issue":"48 Pt A","key":"10.1016\/j.vaccine.2026.128899_bb0145","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1016\/j.vaccine.2017.01.050","article-title":"Dysfunctional labor: case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"35","author":"Boatin","year":"2017","journal-title":"Vaccine"},{"issue":"48 Pt A","key":"10.1016\/j.vaccine.2026.128899_bb0150","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1016\/j.vaccine.2017.01.043","article-title":"Gestational diabetes mellitus: case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"35","author":"Kachikis","year":"2017","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2026.128899_bb0155","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1016\/j.vaccine.2016.03.038","article-title":"Hypertensive disorders of pregnancy: case definitions & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"Rouse","year":"2016","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2026.128899_bb0160","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1016\/j.vaccine.2016.03.054","article-title":"Pathways to preterm birth: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"Harrison","year":"2016","journal-title":"Vaccine"},{"issue":"48 Pt A","key":"10.1016\/j.vaccine.2026.128899_bb0165","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1016\/j.vaccine.2017.01.047","article-title":"Spontaneous abortion and ectopic pregnancy: case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data","volume":"35","author":"Rouse","year":"2017","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2026.128899_bb0170","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1016\/j.vaccine.2016.03.039","article-title":"Postpartum haemorrhage: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"Kerr","year":"2016","journal-title":"Vaccine"},{"issue":"48 Pt A","key":"10.1016\/j.vaccine.2026.128899_bb0175","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1016\/j.vaccine.2017.01.045","article-title":"Neonatal encephalopathy: case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data","volume":"35","author":"Sell","year":"2017","journal-title":"Vaccine"},{"issue":"48 Pt A","key":"10.1016\/j.vaccine.2026.128899_bb0180","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1016\/j.vaccine.2017.01.051","article-title":"Failure to thrive: case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data","volume":"35","author":"Ross","year":"2017","journal-title":"Vaccine"},{"issue":"48 Part A","key":"10.1016\/j.vaccine.2026.128899_bb0185","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1016\/j.vaccine.2017.01.049","article-title":"Low birth weight: case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data","volume":"35","author":"Cutland","year":"2017","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2026.128899_bb0190","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1016\/j.vaccine.2016.03.045","article-title":"Preterm birth: case definition & guidelines for data collection, analysis, and presentation of immunisation safety data","volume":"34","author":"Quinn","year":"2016","journal-title":"Vaccine"},{"issue":"48 Pt A","key":"10.1016\/j.vaccine.2026.128899_bb0195","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1016\/j.vaccine.2017.01.046","article-title":"Respiratory distress in the neonate: case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data","volume":"35","author":"Sweet","year":"2017","journal-title":"Vaccine"},{"issue":"48 Pt A","key":"10.1016\/j.vaccine.2026.128899_bb0200","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1016\/j.vaccine.2017.01.040","article-title":"Small for gestational age: case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data","volume":"35","author":"Schlaudecker","year":"2017","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2026.128899_bb0205","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.1016\/j.vaccine.2016.03.046","article-title":"Neonatal infections: case definition and guidelines for data collection, analysis, and presentation of immunisation safety data","volume":"34","author":"Vergnano","year":"2016","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.vaccine.2026.128899_bb0210","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1016\/j.vaccine.2019.05.030","article-title":"Chorioamnionitis: case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"37","author":"Kachikis","year":"2019","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.vaccine.2026.128899_bb0215","doi-asserted-by":"crossref","first-page":"7596","DOI":"10.1016\/j.vaccine.2019.05.031","article-title":"Neonatal seizures: case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"37","author":"Pellegrin","year":"2019","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.vaccine.2026.128899_bb0220","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.1016\/j.vaccine.2019.05.027","article-title":"Neurodevelopmental delay: case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"37","author":"Villagomez","year":"2019","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.vaccine.2026.128899_bb0225","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1016\/j.vaccine.2019.09.101","article-title":"Postpartum endometritis and infection following incomplete or complete abortion: case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data","volume":"37","author":"Rouse","year":"2019","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:32:38Z","timestamp":1788377558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26007085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"alternative-id":["S0264410X26007085"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128899","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updating the evidence on brighton collaboration's GAIA maternal immunisation case definitions: a systematic review of performance and implementation challenges","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128899"}}